The women filed the lawsuit last Friday against the Milwaukee Bucks, former Bucks guard Patrick Beverley and assistant coach ...

Fintel reports that on February 24, 2025, Oppenheimer upgraded their outlook for BioMarin Pharmaceutical (NasdaqGS:BMRN) from ...

Efforts are ongoing to rehabilitate the Oppenheimer Beach Facility on the island of St. John thanks to a $1 million grant ...

Oppenheimer upgraded BioMarin (BMRN) to Outperform from Perform with a $98 price target BioMarin reported strong Q4 results and Oppenheimer ...

As NVIDIA increases the output of its next-generation Blackwell architecture, its AI hardwareespecially its H200 GPUsis ...

Oppenheimer upgraded shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) from a market perform rating to an outperform rating in a research note published on Monday morning, MarketBeat ...

(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...

Patrick Beverley and the Milwaukee Bucks are reportedly facing legal action over an incident that occurred during the 2024 ...

Oppenheimer downgraded Integer (ITGR) to Perform from Outperform without a price target following the Q4 report. While “fundamentally ...

Oppenheimer said it remains "positive on equities," even amid ongoing trade tensions and tariff uncertainties. Read more here ...

Nvidia is set to report fourth-quarter results after the market closes Wednesday, with analysts widely bullish on the AI chipmaker's stock.